Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Milton

Showing results (161-170 of 182) with videos related to

Pageof 19
Sort By:
Cancer|April 5, 2023
Phase 1b study of combined selinexor and eribulin for the treatment of advanced solid tumors and triple-negative breast cancerBlessie Elizabeth Nelson, Sadia Saleem, Senthil Damodaran, et al.
Leukemia & Lymphoma|January 29, 2026
Lenalidomide maintenance after delayed or salvage autologous stem cell transplantationAsad A Haider, Curtis Marcoux, Denái R Milton, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 27, 2026
Daratumumab-Based Second Line Therapy Improves Outcomes After VRD Induction, Upfront Autologous Transplant, and Lenalidomide MaintenanceOren Pasvolsky, Curtis Marcoux, Denái R Milton, et al.
Cancer Discovery|March 12, 2021
Tilsotolimod with Ipilimumab Drives Tumor Responses in Anti-PD-1 Refractory MelanomaCara Haymaker, Daniel H Johnson, Ravi Murthy, et al.
British Journal of Haematology|March 30, 2025
Outcomes of patients with multiple myeloma undergoing autologous transplant with suboptimal pretransplant responseOren Pasvolsky, Muhammad Bilal Abid, Denái R Milton, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 30, 2014
Similar transplantation outcomes for acute myeloid leukemia and myelodysplastic syndrome patients with haploidentical versus 10/10 human leukocyte antigen-matched unrelated and related donorsAntonio Di Stasi, Denái R Milton, L M Poon, et al.
Journal of Immunotherapy and Precision Oncology|June 6, 2022
Implementation of a Novel Web-Based Lesion Selection Tool to Improve Acquisition of Tumor Biopsy SpecimensMingxuan Xu, Coya Tapia, Joud Hajjar, et al.
Journal of Cutaneous Pathology|May 7, 2023
Gene expression profiling and multiplex immunofluorescence analysis of bullous pemphigoid immune-related adverse event reveal upregulation of toll-like receptor 4/complement-induced innate immune response and increased density of T<sub>H</sub> 1 T-cellsMario L Marques-Piubelli, Riyad N H Seervai, Kumaran M Mudaliar, et al.
The Lancet. Haematology|March 27, 2019
Conditioning with busulfan plus melphalan versus melphalan alone before autologous haemopoietic cell transplantation for multiple myeloma: an open-label, randomised, phase 3 trialQaiser Bashir, Peter F Thall, Denái R Milton, et al.
Transplantation and Cellular Therapy|May 23, 2022
Long-Term Outcomes of Allogeneic Hematopoietic Cell Transplantation in Patients with Newly Diagnosed Multiple MyelomaAimaz Afrough, Leonard C Alsfeld, Denái R Milton, et al.
Pageof 19

Showing results (161-170 of 182) with videos related to

Sort By:
Pageof 19
Cancer|April 5, 2023
Phase 1b study of combined selinexor and eribulin for the treatment of advanced solid tumors and triple-negative breast cancerBlessie Elizabeth Nelson, Sadia Saleem, Senthil Damodaran, et al.
Leukemia & Lymphoma|January 29, 2026
Lenalidomide maintenance after delayed or salvage autologous stem cell transplantationAsad A Haider, Curtis Marcoux, Denái R Milton, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 27, 2026
Daratumumab-Based Second Line Therapy Improves Outcomes After VRD Induction, Upfront Autologous Transplant, and Lenalidomide MaintenanceOren Pasvolsky, Curtis Marcoux, Denái R Milton, et al.
Cancer Discovery|March 12, 2021
Tilsotolimod with Ipilimumab Drives Tumor Responses in Anti-PD-1 Refractory MelanomaCara Haymaker, Daniel H Johnson, Ravi Murthy, et al.
British Journal of Haematology|March 30, 2025
Outcomes of patients with multiple myeloma undergoing autologous transplant with suboptimal pretransplant responseOren Pasvolsky, Muhammad Bilal Abid, Denái R Milton, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 30, 2014
Similar transplantation outcomes for acute myeloid leukemia and myelodysplastic syndrome patients with haploidentical versus 10/10 human leukocyte antigen-matched unrelated and related donorsAntonio Di Stasi, Denái R Milton, L M Poon, et al.
Journal of Immunotherapy and Precision Oncology|June 6, 2022
Implementation of a Novel Web-Based Lesion Selection Tool to Improve Acquisition of Tumor Biopsy SpecimensMingxuan Xu, Coya Tapia, Joud Hajjar, et al.
Journal of Cutaneous Pathology|May 7, 2023
Gene expression profiling and multiplex immunofluorescence analysis of bullous pemphigoid immune-related adverse event reveal upregulation of toll-like receptor 4/complement-induced innate immune response and increased density of T<sub>H</sub> 1 T-cellsMario L Marques-Piubelli, Riyad N H Seervai, Kumaran M Mudaliar, et al.
The Lancet. Haematology|March 27, 2019
Conditioning with busulfan plus melphalan versus melphalan alone before autologous haemopoietic cell transplantation for multiple myeloma: an open-label, randomised, phase 3 trialQaiser Bashir, Peter F Thall, Denái R Milton, et al.
Transplantation and Cellular Therapy|May 23, 2022
Long-Term Outcomes of Allogeneic Hematopoietic Cell Transplantation in Patients with Newly Diagnosed Multiple MyelomaAimaz Afrough, Leonard C Alsfeld, Denái R Milton, et al.
Pageof 19